GLP-1 receptor agonists have gained attention for their role potentially improving cardiovascular health. These therapies have been studied in individuals with diabetes, obesity, and existing heart conditions.
Discover the latest research behind GLP-1s and their potential impact on heart health, along with insights into the FDA's recent approval.